TranXenoGen, Inc.-- Announces Progress on Anti-Neoplastic Urinary Protein Program
November 13, 2003 08:24 ET
|
TranXenoGen, Inc.
SHREWSBURY, U.K., Nov. 13, 2003 (PRIMEZONE) -- TranXenoGen, Inc. ("TranXenoGen") announces today the successful results of animal model studies conducted with peptides derived from Antineoplastic...
TranXenoGen, Inc. -- Interim Results for the Six Months Ended June 30, 2003
September 04, 2003 03:59 ET
|
TranXenoGen, Inc.
SHREWSBURY, Mass., Sept. 4, 2003 (PRIMEZONE) -- TranXenoGen, Inc. (LSE:TXN) ("TranXenoGen" or the "Company"), the avian transgenic company based in Shrewsbury, Massachusetts and listed on the...
TranXenoGen Interim Results
September 05, 2002 06:07 ET
|
TranXenoGen, Inc.
SHREWSBURY, Mass., Sept. 5, 2002 (PRIMEZONE) -- TranXenoGen, Inc. ("TranXenoGen" or the "Company") (LSE:TXN), the avian transgenic company based in Shrewsbury, Massachusetts and listed on the...